F2-isoprostanes:: sensitive and specific non-invasive indices of lipid peroxidation in vivo

被引:153
作者
Praticò, D [1 ]
机构
[1] Ctr Expt Therapeut, Stellar Chance Labs 905, Philadelphia, PA 19104 USA
关键词
F-2-isoprostanes; lipid peroxidation; oxidant stress;
D O I
10.1016/S0021-9150(99)00257-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Isoprostanes are members of a complex family of lipids, isomers of the conventional enzymatically derived prostaglandins (PG), which are produced in vivo primarily, if not exclusively, by a free radical-catalyzed peroxidation of polyunsaturated fatty acids. Most of the work has been focused upon a group of isomers of the enzyme-derived PGF(2 alpha), called F-2-isoprostanes (F-2-iPs). Because of their mechanism of formation, chemical stability and the rapid development of sensitive methods for their measurement, they have the attraction as non-invasive indices of oxidant stress in vivo. Altered generation of F-2-iPs has been reported in a variety of clinical settings putatively associated with oxidant stress. These include atherosclerosis, chronic obstructive pulmonary disease and Alzheimer's disease. Furthermore, the measurement of specific F-2-iPs may provide a sensitive biochemical basis for rational dose-selection of natural and synthetic inhibitor of lipid peroxidation. Although F-2-iPs possess biological activities in vitro and in vivo, much remains to be learned about their role and as mediators of the cellular effects of lipid peroxidation and oxidant stress. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 90 条
[81]   Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid [J].
Roberts, LJ ;
Montine, TJ ;
Markesbery, WR ;
Tapper, AR ;
Hardy, P ;
Chemtob, S ;
Dettbarn, WD ;
Morrow, JD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (22) :13605-13612
[82]   Nomenclature of isoprostanes: A proposal [J].
Rokach, J ;
Khanapure, SP ;
Hwang, SW ;
Adiyaman, M ;
Lawson, JA ;
FitzGerald, GA .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1997, 54 (06) :853-873
[83]   The isoprostanes: A perspective [J].
Rokach, J ;
Khanapure, SP ;
Hwang, SW ;
Adiyaman, M ;
Lawson, JA ;
FitzGerald, GA .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1997, 54 (06) :823-851
[84]  
Steinberg D, 1997, CIRCULATION, V95, P1062
[85]   A nomenclature system for the isoprostanes [J].
Taber, DF ;
Morrow, JD ;
Roberts, LJ .
PROSTAGLANDINS, 1997, 53 (02) :63-67
[86]   GLOMERULAR ACTIONS OF A FREE RADICAL-GENERATED NOVEL PROSTAGLANDIN, 8-EPI-PROSTAGLANDIN-F2-ALPHA, IN THE RAT - EVIDENCE FOR INTERACTION WITH THROMBOXANE-A2 RECEPTORS [J].
TAKAHASHI, K ;
NAMMOUR, TM ;
FUKUNAGA, M ;
EBERT, J ;
MORROW, JD ;
ROBERTS, LJ ;
HOOVER, RL ;
BADR, KF .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (01) :136-141
[87]   ANTICARDIOLIPIN ANTIBODIES AND RISK OF MYOCARDIAL-INFARCTION IN A PROSPECTIVE COHORT OF MIDDLE-AGED MEN [J].
VAARALA, O ;
MANTTARI, M ;
MANNINEN, V ;
TENKANEN, L ;
PUURUNEN, M ;
AHO, K ;
PALOSUO, T .
CIRCULATION, 1995, 91 (01) :23-27
[88]  
WANG ZY, 1995, J PHARMACOL EXP THER, V275, P94
[89]   Mass spectrometric analysis of four regioisomers of F-2-isoprostanes formed by free radical oxidation of arachidonic acid [J].
Waugh, RJ ;
Murphy, RC .
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY, 1996, 7 (05) :490-499
[90]   Oxidized phospholipids and isoprostanes in atherosclerosis [J].
Witztum, JL ;
Berliner, JA .
CURRENT OPINION IN LIPIDOLOGY, 1998, 9 (05) :441-448